La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sleep disorders and their determinants in multiple system atrophy.

Identifieur interne : 001145 ( PubMed/Curation ); précédent : 001144; suivant : 001146

Sleep disorders and their determinants in multiple system atrophy.

Auteurs : I. Ghorayeb [France] ; F. Yekhlef ; V. Chrysostome ; E. Balestre ; B. Bioulac ; F. Tison

Source :

RBID : pubmed:12023429

English descriptors

Abstract

To evaluate the incidence, types, determinants, and consequences of sleep disorders in patients with multiple system atrophy (MSA) and determine whether their characteristics are similar to those of patients with Parkinson's disease (PD).

PubMed: 12023429

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:12023429

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Sleep disorders and their determinants in multiple system atrophy.</title>
<author>
<name sortKey="Ghorayeb, I" sort="Ghorayeb, I" uniqKey="Ghorayeb I" first="I" last="Ghorayeb">I. Ghorayeb</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service d'Explorations Fonctionnelles du Systéme Nerveux, Clinique du Sommeil, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'Explorations Fonctionnelles du Systéme Nerveux, Clinique du Sommeil, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux cedex</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yekhlef, F" sort="Yekhlef, F" uniqKey="Yekhlef F" first="F" last="Yekhlef">F. Yekhlef</name>
</author>
<author>
<name sortKey="Chrysostome, V" sort="Chrysostome, V" uniqKey="Chrysostome V" first="V" last="Chrysostome">V. Chrysostome</name>
</author>
<author>
<name sortKey="Balestre, E" sort="Balestre, E" uniqKey="Balestre E" first="E" last="Balestre">E. Balestre</name>
</author>
<author>
<name sortKey="Bioulac, B" sort="Bioulac, B" uniqKey="Bioulac B" first="B" last="Bioulac">B. Bioulac</name>
</author>
<author>
<name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F" last="Tison">F. Tison</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12023429</idno>
<idno type="pmid">12023429</idno>
<idno type="wicri:Area/PubMed/Corpus">001186</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001186</idno>
<idno type="wicri:Area/PubMed/Curation">001145</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001145</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Sleep disorders and their determinants in multiple system atrophy.</title>
<author>
<name sortKey="Ghorayeb, I" sort="Ghorayeb, I" uniqKey="Ghorayeb I" first="I" last="Ghorayeb">I. Ghorayeb</name>
<affiliation wicri:level="1">
<nlm:affiliation>Service d'Explorations Fonctionnelles du Systéme Nerveux, Clinique du Sommeil, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service d'Explorations Fonctionnelles du Systéme Nerveux, Clinique du Sommeil, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux cedex</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Yekhlef, F" sort="Yekhlef, F" uniqKey="Yekhlef F" first="F" last="Yekhlef">F. Yekhlef</name>
</author>
<author>
<name sortKey="Chrysostome, V" sort="Chrysostome, V" uniqKey="Chrysostome V" first="V" last="Chrysostome">V. Chrysostome</name>
</author>
<author>
<name sortKey="Balestre, E" sort="Balestre, E" uniqKey="Balestre E" first="E" last="Balestre">E. Balestre</name>
</author>
<author>
<name sortKey="Bioulac, B" sort="Bioulac, B" uniqKey="Bioulac B" first="B" last="Bioulac">B. Bioulac</name>
</author>
<author>
<name sortKey="Tison, F" sort="Tison, F" uniqKey="Tison F" first="F" last="Tison">F. Tison</name>
</author>
</analytic>
<series>
<title level="j">Journal of neurology, neurosurgery, and psychiatry</title>
<idno type="ISSN">0022-3050</idno>
<imprint>
<date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Depression</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multiple System Atrophy (complications)</term>
<term>Parkinson Disease (complications)</term>
<term>Severity of Illness Index</term>
<term>Sleep Wake Disorders (epidemiology)</term>
<term>Sleep Wake Disorders (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Multiple System Atrophy</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Sleep Wake Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Sleep Wake Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Depression</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">To evaluate the incidence, types, determinants, and consequences of sleep disorders in patients with multiple system atrophy (MSA) and determine whether their characteristics are similar to those of patients with Parkinson's disease (PD).</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">12023429</PMID>
<DateCreated>
<Year>2002</Year>
<Month>05</Month>
<Day>22</Day>
</DateCreated>
<DateCompleted>
<Year>2002</Year>
<Month>06</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0022-3050</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>72</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2002</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of neurology, neurosurgery, and psychiatry</Title>
<ISOAbbreviation>J. Neurol. Neurosurg. Psychiatr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sleep disorders and their determinants in multiple system atrophy.</ArticleTitle>
<Pagination>
<MedlinePgn>798-800</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the incidence, types, determinants, and consequences of sleep disorders in patients with multiple system atrophy (MSA) and determine whether their characteristics are similar to those of patients with Parkinson's disease (PD).</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Information about sleep disorders was collected using a standardised questionnaire in an unselected group of 57 patients with MSA and in 62 patients with PD matched as a group for age, sex distribution, and disease duration.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy percent of patients with MSA complained of sleep disorders compared with 51% of patients with PD (p=0.03). The most commonly reported sleep disorders were sleep fragmentation (52.5%), vocalisation (60%), REM sleep behaviour disorder (47.5%), and nocturnal stridor (19%). Except for sleep fragmentation, the incidence of these disorders was significantly higher than in PD. Sleep problems tended to be associated with more severe motor symptoms, longer disease duration, depression, and longer duration of levodopa treatment. Half of patients with MSA with sleep disorders complained of daytime somnolence compared with 30% of patients with PD. Daytime somnolence was significantly associated with disease severity in MSA.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study shows that sleep disorders are more common in patients with MSA than in those with PD after the same duration of the disease, reflecting the more diffuse underlying pathological process in MSA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ghorayeb</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Service d'Explorations Fonctionnelles du Systéme Nerveux, Clinique du Sommeil, Hôpital Pellegrin, Place Amélie Raba-Léon, 33076 Bordeaux cedex, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Yekhlef</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chrysostome</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Balestre</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bioulac</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Tison</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA>
<NlmUniqueID>2985191R</NlmUniqueID>
<ISSNLinking>0022-3050</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000978" MajorTopicYN="N">Antiparkinson Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019578" MajorTopicYN="N">Multiple System Atrophy</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012893" MajorTopicYN="N">Sleep Wake Disorders</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC1737902</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2002</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2002</Year>
<Month>6</Month>
<Day>26</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2002</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">12023429</ArticleId>
<ArticleId IdType="pmc">PMC1737902</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001145 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001145 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:12023429
   |texte=   Sleep disorders and their determinants in multiple system atrophy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:12023429" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024